New PMA Requirement Proposed For Apparently Nonexistent Devices
This article was originally published in The Gray Sheet
Executive Summary
CDRH is proposing to require PMAs for four categories of devices for the first time, but it is not likely to hear much resistance from industry
You may also be interested in...
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.
FDA Panel Says Breast Transilluminators Should Remain Class III
FDA’s Radiological Devices Panel recommends that pre-amendment breast transilluminator devices should stay as class III devices.
U-Systems’ somo-v Breast Ultrasound Device Heads To Panel
Radiological devices panel will review U-Systems’ PMA for breast cancer screening on April 11. The next day, the panel will discuss potential reclassification of pre-amendment breast transilluminator devices and the classification of blood irradiators.